The risks and consequences of a motor vehicle crash in older adults with Alzheimer's Disease and Related Dementias
患有阿尔茨海默病和相关痴呆症的老年人发生车祸的风险和后果
基本信息
- 批准号:10677800
- 负责人:
- 金额:$ 75.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-15 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAlzheimer&aposs DiseaseAlzheimer&aposs disease diagnosisAlzheimer&aposs disease related dementiaAlzheimer&aposs disease riskAssisted Living FacilitiesAutomobile DrivingCaringCharacteristicsClinicalClinical Course of DiseaseCognitiveDataData SourcesDementiaDiagnosisDiseaseElderlyEventGoalsHealthHospitalizationImpaired cognitionIndividualInterventionKnowledgeLicensingLinkLiteratureLong-Term CareLongitudinal trendsMasksMeasuresMedicalMedicareMedicare claimModelingNew JerseyOutcomePatternPatterns of CarePhasePoliciesPopulation StudyProviderReportingResearchRiskRisk EstimateRisk ReductionSafetySensorySentinelServicesSourceSuspensionsTimeVariantVehicle crashcare outcomesclinical diagnosiscomorbiditydriving behaviordriving safetyevidence baseexperiencefunctional statushealth care service utilizationhigh riskimprovedindividual variationinsurance claimsmild cognitive impairmentnovelolder driverpsychologicresidential care facilitysocialunsafe driving
项目摘要
PROJECT SUMMARY
Older adults with Alzheimer's Disease (AD) and related dementia disorders are at increased risk of a motor
vehicle crash due to impairment of the cognitive and sensory functions necessary for safe driving.1 Because
there are few sources of long-term longitudinal data on dementia and motor vehicle crashes, and even fewer
that include the prodromal stage of AD related dementia called mild cognitive impairment (MCI), very little is
known about how the risk of a crash changes over the course of AD and how a crash may change the clinical
course of disease. Here, we propose to use a novel data source of Medicare insurance claims linked to licensing,
citation, and crash data for more than 1.5 million older drivers over a 13-year period to evaluate longitudinal
changes in the risk of a crash and changes in the trajectory of health, health care utilization, and long-term care
assistance following a crash, among older drivers with AD. The lack of information on the longitudinal risks and
consequences of a crash among older adults with AD represents a critical gap in the literature for two reasons.
First, research suggests that there is substantial individual variation in driving ability by stage of disease. While
some individuals demonstrate a significant increase in unsafe driving behaviors early in the course of disease,
before they are even diagnosed, others are able to drive safely with MCI through the mild to moderate stage of
AD.2 As the number of older drivers with AD grows, providers and organizations that serve older adults are
increasingly focused on developing interventions to promote “safe-mobility,” allowing older adults to drive for as
long as is safely possible. However, to be effective, interventions need to account for longitudinal changes in the
risk of a crash over time, and how these trajectories may vary across individual characteristics. Second, the
effects of a crash can have long-lasting physical, psychological and social consequences. Current studies have
identified short term effects of a crash,5 but no study has followed crash-involved-drivers with AD for long enough
to understand how the impact of a crash manifests over time. Individuals with AD are already at higher risk of
comorbidity, hospitalization, and early transition to long term care. Thus, given the rise in licensed drivers with
AD, it is critical to understand how a crash may compound these risks. A major barrier to identifying periods of
high crash risk and the contributing factors is the lack of longitudinal data on motor vehicle crashes. Instead,
most studies have evaluated individuals retrospectively at a particular stage of the disease or followed older
adults for relatively short periods of time and without knowledge of their cognitive status, making it difficult to
identify longitudinal patterns of crash risk. Here, we propose to use 13 years of Medicare claims data linked to
licensing, crash and citations for all drivers with a license in New Jersey between 2007 and 2019 to (1)
characterize the longitudinal trajectories of crash risk over time (2) identify sentinel points in these trajectories
where the risk of crash is highest and thus interventions would be most effective and (3) evaluate the impact of
a crash on the health and health care outcomes for cognitively impaired older drivers.
项目总结
患有阿尔茨海默病(AD)和相关痴呆症的老年人患运动障碍的风险增加
由于安全驾驶所必需的认知和感觉功能受损而造成的车祸1
关于痴呆症和车祸的长期纵向数据来源很少,甚至更少
这包括AD相关痴呆的前驱阶段,称为轻度认知障碍(MCI),很少是
了解AD过程中撞车风险如何变化,以及撞车可能如何改变临床
病程。在这里,我们建议使用与许可相关联的医疗保险保险索赔的新数据源,
引用了超过150万名老年司机13年来的碰撞数据,以评估纵向
崩溃风险的变化以及健康、卫生保健利用和长期护理轨迹的变化
撞车后的帮助,在患有AD的老年司机中。缺乏关于纵向风险和
老年阿尔茨海默病患者中撞车的后果代表了文献中的一个关键差距,原因有两个。
首先,研究表明,驾驶能力因疾病阶段的不同而有很大的个体差异。而当
一些人在疾病早期表现出不安全驾驶行为的显著增加,
甚至在被诊断之前,其他人就能够安全地驾驶MCI通过轻度到中度的
AD.2随着患有AD的老年司机数量的增加,为老年人提供服务的提供者和组织
越来越多地专注于开发干预措施,以促进“安全移动”,允许老年人驾车前往AS
在安全的情况下尽可能长时间。然而,为了有效,干预措施需要考虑到
随着时间的推移,崩溃的风险,以及这些轨迹可能如何随着个人特征的变化而变化。第二,
坠机的影响可能会产生长期的生理、心理和社会后果。目前的研究已经
确定了车祸的短期影响,5但没有研究对车祸相关的司机进行足够长时间的AD跟踪调查
以了解坠机的影响是如何随着时间的推移而显现的。患有阿尔茨海默病的人已经有更高的风险
合并症、住院和早期过渡到长期护理。因此,鉴于持有执照的司机数量的增加,
AD,关键是要了解崩盘可能会如何加剧这些风险。确定以下阶段的主要障碍
高碰撞风险和促成因素是缺乏关于机动车碰撞的纵向数据。相反,
大多数研究都在疾病的特定阶段对个体进行了回顾性评估,或者跟踪了年龄较大的个体。
成年人的时间相对较短,对自己的认知状况一无所知,因此很难
确定碰撞风险的纵向模式。在这里,我们建议使用13年的联邦医疗保险索赔数据与
2007年至2019年期间新泽西州所有持有驾照的司机的执照、撞车和传票(1)
描述事故风险随时间变化的纵向轨迹(2)确定这些轨迹中的哨点
碰撞风险最高的地方,因此干预措施将是最有效的;和(3)评估
对认知受损的老年司机的健康和医疗保健结果的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nina Joyce其他文献
Nina Joyce的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nina Joyce', 18)}}的其他基金
The risks and consequences of a motor vehicle crash in older adults with Alzheimer's Disease and Related Dementias
患有阿尔茨海默病和相关痴呆症的老年人发生车祸的风险和后果
- 批准号:
10524893 - 财政年份:2022
- 资助金额:
$ 75.25万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 75.25万 - 项目类别:
Research Grant